International 3 of 8

World Health Organization issues the second edition of its tuberculosis diagnosis guidelines

The World Health Organization has published the second edition of Module 3 of its consolidated guidelines on tuberculosis, the module that deals with diagnosis. The edition brings together in one document the agency's policy guidance on detecting tuberculosis infection, tuberculosis disease and drug resistance, which had been issued separately until now. Three recommendations are new. The first allows a class of near point-of-care diagnostic tests that can confirm tuberculosis at peripheral levels of a health system, rather than only at referral laboratories. The second accepts tongue swabs as a sample type, which matters for patients who cannot produce sputum, including many children and people living with HIV. The third permits sputum pooling, in which samples from several people are tested together, as a way to diagnose tuberculosis and rifampicin resistance more cheaply where resources are very tight. The consolidated guidelines series is the reference that national tuberculosis programmes follow.

Publication: WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis, 2nd edition New sample type accepted: Tongue swabs Resistance marker covered: Rifampicin resistance
Why it matters for exams: The WHO consolidated guidelines on tuberculosis are the global reference that national TB programmes follow, and rifampicin resistance is the marker used to flag drug-resistant tuberculosis.
Kerala PSCUPSC
3 November 2026 Source: World Health Organization

In plain words

WHO World Health Organization — The United Nations specialised agency for health, with headquarters at Geneva.

On a phone, swipe left or right to move between stories.